The place of guanfacine in the treatment of essential arterial hypertension
Koaté, P.; Diouf, S.; Sylla, M.; Sarr, M.; Ba, S.A.
Dakar Medical 28(2): 321-336
1983
ISSN/ISBN: 0049-1101 PMID: 6360603 Document Number: 198609
Document emailed within 1 workday
Related Documents
Monova, D.; Daskalova, I.; Belovezhdov, N. 1990: Guanfacine in the treatment of arterial hypertension in diabetics Vutreshni Bolesti 29(6): 44-47Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Román, O.; Valenzuela, M.A.; Salazar, R. 1982: Guanfacine in primary arterial hypertension: a long-term open clinical study Revista Medica de Chile 110(12): 1179-1184
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Paladini, G.; Sgoifo, E. 1980: Dioodobufenine in the treatment of essential arterial hypertension Minerva Cardioangiologica 28(5): 303-308
Pérez-Grovas, H.; Fernández, M.; Arriaga, J.; Herrera-Acosta, J. 1986: Enalapril in the treatment of essential arterial hypertension Archivos del Instituto de Cardiologia de Mexico 56(5): 379-390
Garnier, L.F. 1988: Essential arterial hypertension. from notion to treatment Annales de Cardiologie et d'Angeiologie 37(7): 371-380
Ghiuru, R.; Rezuş, C.; Ambăruş, V.; Ionescu, S.; Cosovanu, A. 2001: Nebivolol treatment in essential arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 105(4): 756-759
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Paris, J.V.; González, C.A. 1991: Nicardipine and nifedipine in the treatment of essential arterial hypertension Proceedings of the Western Pharmacology Society 34: 303-309
Marchetta, F.; Chiarini, C.; Degli Esposti, E.; Santoro, A.; Sturani, A.; Zuccalà, A.; Zucchelli, P. 1983: Treatment of essential arterial hypertension with nadolol and bendroflumethiazide La Clinica Terapeutica 106(3): 209-212
Papi, L.; Ballestra, A.M.; Tomei, G.; Filice, M.; Giustarini, C. 1981: Evaluation of the efficacy of indapamide in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 26(11): 1585-1588
García-Ortiz, R.E. 1992: Diuretics and their current role in the treatment of essential arterial hypertension Revista Medica de Chile 120(6): 680-684
Passeron, J.; Pauly, N.; Desprat, J. 1981: International multicentre study of indapamide in the treatment of essential arterial hypertension Postgraduate Medical Journal 57 Suppl. 2: 57-59
Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Forattini, C.; Perin, S. 1988: Combination captopril-hydrochlorothiazide in a single dose for treatment of essential arterial hypertension Rivista Europea Per le Scienze Mediche e Farmacologiche 10(1): 63-67
Mariani, A.; Brun, M.; Rongoni, R.; Mariotti, W.; Caporicci, D. 1987: Treatment of essential systemic arterial hypertension with captopril only. Evaluation especially in aged patients La Clinica Terapeutica 121(5): 401-409
1998: Medical recommendations and references of ANAES. Diagnosis and treatment of essential arterial hypertension in adults aged 20 to 80 years Journal des Maladies Vasculaires 23(3): 204-231
Gassia, J.P.; Durand, D.; Suc, J.M. 1979: Essential arterial hypertension: initial therapeutic strategy or how to normalize arterial pressure La Revue du Praticien 29(57): 4395-4407
Duprez, D.A.; De Buyzere, M.L.; Verloove, H.H.; Kaufman, J.M.; Van Hoecke, M.J.; Clement, D.L. 1996: Influence of the arterial blood pressure and nonhemodynamic factors on regional arterial wall properties in moderate essential hypertension Journal of Human Hypertension 10(4): 251-256